68.00
+1.00
+(1.49%)
At close: 9:06:55 AM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
Total Revenue
419,674.00
403,556.00
139,443.00
Cost of Revenue
274,829.00
252,501.00
89,569.00
Gross Profit
144,845.00
151,055.00
49,874.00
Operating Expense
51,401.00
48,080.00
16,806.00
Operating Income
93,444.00
102,975.00
33,068.00
Net Non Operating Interest Income Expense
-3,438.00
-1,751.00
-1,031.00
Pretax Income
92,983.00
102,709.00
31,509.00
Tax Provision
17,096.00
20,331.00
1,898.00
Net Income Common Stockholders
75,887.00
82,378.00
29,611.00
Diluted NI Available to Com Stockholders
75,887.00
82,378.00
29,611.00
Basic EPS
5.51
6.15
2.30
Diluted EPS
5.36
6.00
2.30
Basic Average Shares
14,773.01
13,394.80
12,874.35
Diluted Average Shares
15,169.84
13,729.67
12,874.35
Total Expenses
326,230.00
300,581.00
106,375.00
Net Income from Continuing & Discontinued Operation
75,887.00
82,378.00
29,611.00
Normalized Income
75,887.00
82,302.61
29,699.34
Interest Income
459.00
393.00
56.00
Interest Expense
3,897.00
2,144.00
1,087.00
Net Interest Income
-3,438.00
-1,751.00
-1,031.00
EBIT
96,880.00
104,853.00
32,596.00
EBITDA
121,788.00
129,513.00
57,575.00
Reconciled Cost of Revenue
274,829.00
252,501.00
89,569.00
Reconciled Depreciation
24,908.00
24,660.00
24,979.00
Net Income from Continuing Operation Net Minority Interest
75,887.00
82,378.00
29,611.00
Total Unusual Items Excluding Goodwill
--
94.00
-94.00
Total Unusual Items
--
94.00
-94.00
Normalized EBITDA
121,788.00
129,419.00
57,669.00
Tax Rate for Calcs
0.00
0.00
0.00
Tax Effect of Unusual Items
--
18.61
-5.66
12/31/2022 - 12/12/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
7814.TWO HORIEN
33.00
-4.76%
1295.TWO Synbio Tech Inc.
74.30
-0.27%
7808.TWO BIONET TX Corp
46.00
-1.08%
7790.TWO SSLab
72.00
+0.28%
7773.TWO FullHope
42.50
-1.62%
6879.TWO TCI GENE Inc.
52.00
0.00%
6986.TWO HeXun Biosciences Co., Ltd.
71.80
+1.84%
4170.TWO VBI
14.10
+0.71%
6945.TWO AP Biosciences Inc
50.80
-3.05%
7427.TWO Great Novel Therapeutics Biotech & Medicals
31.75
+0.47%